129 related articles for article (PubMed ID: 22572382)
1. The responses of the hepatic and splanchnic vascular beds to vasopressin in rats.
Zhang W; Shibamoto T; Kuda Y; Shinomiya S; Kurata Y
Biomed Res; 2012 Apr; 33(2):83-8. PubMed ID: 22572382
[TBL] [Abstract][Full Text] [Related]
2. Vasopressin-induced changes in splanchnic blood flow and hepatic and portal venous pressures in liver resection.
Bown LS; Ricksten SE; Houltz E; Einarsson H; Söndergaard S; Rizell M; Lundin S
Acta Anaesthesiol Scand; 2016 May; 60(5):607-15. PubMed ID: 26763649
[TBL] [Abstract][Full Text] [Related]
3. Vasopressin and nitroglycerin decrease portal and hepatic venous pressure and hepato-splanchnic blood flow.
Wisén E; Svennerholm K; Bown LS; Houltz E; Rizell M; Lundin S; Ricksten SE
Acta Anaesthesiol Scand; 2018 Aug; 62(7):953-961. PubMed ID: 29578250
[TBL] [Abstract][Full Text] [Related]
4. Mouse hepatic portal venoconstrictive response to vasoconstrictors is much weaker than that in rat.
Zhao ZS; Shibamoto T; Tsutsumi M; Cui S; Zhang WM; Takano H; Kurata Y
J Cardiovasc Pharmacol; 2009 Nov; 54(5):421-6. PubMed ID: 19940641
[TBL] [Abstract][Full Text] [Related]
5. Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension.
Bernadich C; Bandi JC; Melin P; Bosch J
Hepatology; 1998 Feb; 27(2):351-6. PubMed ID: 9462630
[TBL] [Abstract][Full Text] [Related]
6. Hepatic venoconstriction is involved in anaphylactic hypotension in rats.
Shibamoto T; Cui S; Ruan Z; Liu W; Takano H; Kurata Y
Am J Physiol Heart Circ Physiol; 2005 Oct; 289(4):H1436-41. PubMed ID: 15923315
[TBL] [Abstract][Full Text] [Related]
7. Lack of vasopressin action on splanchnic hemodynamics during bleeding: a study in conscious, portal hypertensive rats.
Valla D; Girod C; Lee SS; Braillon A; Lebrec D
Hepatology; 1988; 8(1):10-5. PubMed ID: 3257454
[TBL] [Abstract][Full Text] [Related]
8. Systemic vasoconstriction modulates the responses of pulmonary vasculature and airway to vasoconstrictors in anesthetized rats.
Wang M; Shibamoto T; Kuda Y; Tanida M; Kurata Y
Exp Lung Res; 2015; 41(6):324-34. PubMed ID: 26151368
[TBL] [Abstract][Full Text] [Related]
9. Vasopressin reverses mesenteric hyperemia and vasoconstrictor hyporesponsiveness in anesthetized portal hypertensive rats.
Heinemann A; Wachter CH; Fickert P; Trauner M; Stauber RE
Hepatology; 1998 Sep; 28(3):646-54. PubMed ID: 9731553
[TBL] [Abstract][Full Text] [Related]
10. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
[TBL] [Abstract][Full Text] [Related]
11. Effects of vasopressin on haemodynamics in portal hypertensive rats receiving clonidine.
Moreau R; Cailmail S; Lebrec D
Liver; 1994 Feb; 14(1):45-9. PubMed ID: 8177029
[TBL] [Abstract][Full Text] [Related]
12. Glytan decreases portal pressure via mesentery vasoconstriction in portal hypertensive rats.
Du QH; Han L; Jiang JJ; Xu Y; Li WH; Li PT; Wang XY; Jia X
World J Gastroenterol; 2014 Nov; 20(44):16674-82. PubMed ID: 25469036
[TBL] [Abstract][Full Text] [Related]
13. Restriction of drinking water abrogates splanchnic vasodilation and portal hypertension in portal vein-ligated rats.
Heinemann A; Schuligoi R; Lippe IT; Stauber RE
Pharmacology; 2009; 83(1):26-32. PubMed ID: 18987488
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
[TBL] [Abstract][Full Text] [Related]
15. Hepatic microvascular pressure during anaphylactic shock in anesthetized rats.
Takano H; Shibamoto T; Zhang W; Kurata Y; Toga H
Microvasc Res; 2009 Sep; 78(2):169-73. PubMed ID: 19573539
[TBL] [Abstract][Full Text] [Related]
16. Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension.
Groszmann RJ; Kravetz D; Bosch J; Glickman M; Bruix J; Bredfeldt J; Conn HO; Rodes J; Storer EH
Hepatology; 1982; 2(6):757-62. PubMed ID: 6815044
[TBL] [Abstract][Full Text] [Related]
17. Splanchnic clearance of plasma vasopressin in the dog: evidence for prehepatic extraction.
Matsui K; Share L; Brooks DP; Crofton JT; Rockhold RW
Am J Physiol; 1983 Dec; 245(6):E611-5. PubMed ID: 6660291
[TBL] [Abstract][Full Text] [Related]
18. The effect of continuous vasopressin infusion on splanchnic blood flow, liver function, and portal and central venous pressures in patients with cirrhosis.
Ranek L; Vilstrup H; Iversen J; Petersen P; Milandri M
Scand J Clin Lab Invest; 1984 May; 44(3):251-6. PubMed ID: 6610200
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic steatohepatitis induces non-fibrosis-related portal hypertension associated with splanchnic vasodilation and signs of a hyperdynamic circulation in vitro and in vivo in a rat model.
Francque S; Wamutu S; Chatterjee S; Van Marck E; Herman A; Ramon A; Jung A; Vermeulen W; De Winter B; Pelckmans P; Michielsen P
Liver Int; 2010 Mar; 30(3):365-75. PubMed ID: 19840249
[TBL] [Abstract][Full Text] [Related]
20. The effects of intra-arterial and intraportal injections of vasopressin on the simultaneously perfused hepatic arterial and portal venous vascular beds of the dog.
Richardson PD; Withrington PG
Circ Res; 1978 Oct; 43(4):496-503. PubMed ID: 688553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
